Operating Income Summary of Medistim ASA

Medistim ASA's latest annual operating income in 2023 was 131.44 Million NOK , down -6.94% from previous year.
Medistim ASA's latest quarterly operating income in 2024 Q3 was 31.9 Million NOK , down -22.66% from previous quarter.
Medistim ASA reported an annual operating income of 141.25 Million NOK in 2022, up 21.48% from previous year.
Medistim ASA reported an annual operating income of 116.27 Million NOK in 2021, up 21.78% from previous year.
Medistim ASA reported a quarterly operating income of 31.9 Million NOK for 2024 Q3, down -22.66% from previous quarter.
Medistim ASA reported a quarterly operating income of 32.06 Million NOK for 2024 Q1, up 44.07% from previous quarter.

Annual Operating Income Chart of Medistim ASA (2023 - 2004)

Historical Annual Operating Income of Medistim ASA (2023 - 2004)

Year	Operating Income	Operating Income Growth
2023	131.44 Million NOK	-6.94%
2022	141.25 Million NOK	21.48%
2021	116.27 Million NOK	21.78%
2020	95.48 Million NOK	6.37%
2019	89.76 Million NOK	21.35%
2018	73.97 Million NOK	12.99%
2017	65.47 Million NOK	16.17%
2016	56.35 Million NOK	12.13%
2015	50.25 Million NOK	15.9%
2014	43.36 Million NOK	21.79%
2013	35.6 Million NOK	-13.43%
2012	41.12 Million NOK	72.34%
2011	23.86 Million NOK	-1.4%
2010	24.2 Million NOK	-15.14%
2009	28.52 Million NOK	17.11%
2008	24.35 Million NOK	21.79%
2007	19.99 Million NOK	-79.24%
2006	96.31 Million NOK	21.14%
2005	79.5 Million NOK	6.69%
2004	74.51 Million NOK	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	41.25 Million NOK	28.65%
2024 Q3	31.9 Million NOK	-22.66%
2024 Q1	32.06 Million NOK	44.07%
2023 FY	131.44 Million NOK	-6.94%
2023 Q3	33.51 Million NOK	-20.6%
2023 Q4	22.25 Million NOK	-33.59%
2023 Q1	33.45 Million NOK	24.36%
2023 Q2	42.21 Million NOK	26.2%
2022 Q1	33.42 Million NOK	71.73%
2022 Q3	34.01 Million NOK	-8.9%
2022 Q4	26.9 Million NOK	-20.92%
2022 FY	141.25 Million NOK	21.48%
2022 Q2	37.33 Million NOK	11.73%
2021 Q4	19.46 Million NOK	-22.4%
2021 FY	116.27 Million NOK	21.78%
2021 Q2	42.67 Million NOK	46.82%
2021 Q1	29.06 Million NOK	31.3%
2021 Q3	25.07 Million NOK	-41.24%
2020 FY	95.48 Million NOK	6.37%
2020 Q1	24.78 Million NOK	25.47%
2020 Q2	27.71 Million NOK	11.8%
2020 Q3	20.85 Million NOK	-24.75%
2020 Q4	22.13 Million NOK	6.16%
2019 Q1	19.94 Million NOK	-28.14%
2019 Q2	30.89 Million NOK	54.89%
2019 FY	89.76 Million NOK	21.35%
2019 Q4	19.75 Million NOK	3.0%
2019 Q3	19.17 Million NOK	-37.92%
2018 Q4	27.75 Million NOK	91.27%
2018 Q2	18.12 Million NOK	33.4%
2018 Q1	13.58 Million NOK	-16.98%
2018 FY	73.97 Million NOK	12.99%
2018 Q3	14.51 Million NOK	-19.95%
2017 Q4	16.36 Million NOK	-15.76%
2017 Q2	13.62 Million NOK	-15.05%
2017 FY	65.47 Million NOK	16.17%
2017 Q3	19.43 Million NOK	42.56%
2017 Q1	16.04 Million NOK	64.56%
2016 Q1	13.53 Million NOK	-15.32%
2016 FY	56.35 Million NOK	12.13%
2016 Q4	9.74 Million NOK	-39.0%
2016 Q3	15.98 Million NOK	-6.44%
2016 Q2	17.08 Million NOK	26.18%
2015 Q1	9.87 Million NOK	-31.69%
2015 FY	50.25 Million NOK	15.9%
2015 Q4	15.98 Million NOK	26.31%
2015 Q3	12.65 Million NOK	7.82%
2015 Q2	11.74 Million NOK	18.95%
2014 FY	43.36 Million NOK	21.79%
2014 Q4	14.44 Million NOK	44.17%
2014 Q3	10.02 Million NOK	-14.13%
2014 Q2	11.67 Million NOK	61.67%
2014 Q1	7.21 Million NOK	-19.64%
2013 Q4	8.98 Million NOK	38.09%
2013 Q3	6.5 Million NOK	-49.3%
2013 FY	35.6 Million NOK	-13.43%
2013 Q2	12.83 Million NOK	76.1%
2013 Q1	7.28 Million NOK	19.97%
2012 Q2	10.32 Million NOK	35.96%
2012 Q3	17.14 Million NOK	66.06%
2012 Q4	6.07 Million NOK	-64.57%
2012 FY	41.12 Million NOK	72.34%
2012 Q1	7.59 Million NOK	104.2%
2011 Q4	3.71 Million NOK	-22.94%
2011 FY	23.86 Million NOK	-1.4%
2011 Q2	8.83 Million NOK	36.14%
2011 Q3	4.82 Million NOK	-45.38%
2011 Q1	6.48 Million NOK	3.16%
2010 FY	24.2 Million NOK	-15.14%
2010 Q4	6.28 Million NOK	24.86%
2010 Q3	5.03 Million NOK	-47.26%
2010 Q2	9.55 Million NOK	187.08%
2010 Q1	3.32 Million NOK	83.2%
2009 Q2	9.24 Million NOK	14.45%
2009 Q1	8.07 Million NOK	0.0%
2009 FY	28.52 Million NOK	17.11%
2009 Q4	1.81 Million NOK	-80.66%
2009 Q3	9.39 Million NOK	1.63%
2008 FY	24.35 Million NOK	21.79%
2007 FY	19.99 Million NOK	-79.24%
2006 FY	96.31 Million NOK	21.14%
2005 FY	79.5 Million NOK	6.69%
2004 FY	74.51 Million NOK	0.0%

Peer Operating Income Comparison of Medistim ASA

Name	Operating Income	Operating Income Difference
Gentian Diagnostics ASA	-12.76 Million NOK	1129.948%
Lifecare AS	-35.34 Million NOK	471.854%

Global Stocks Search

Medistim ASA (MEDI.OL)

Operating Income Summary of Medistim ASA

Annual Operating Income Chart of Medistim ASA (2023 - 2004)

Historical Annual Operating Income of Medistim ASA (2023 - 2004)

Peer Operating Income Comparison of Medistim ASA